Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To evaluate the proportion of patients who achieve RVR with DEB025 600mg QD plus RBV 400 mg BID, DEB025 800 mg QD plus RBV 400 mg BID and DEB025 1000 mg QD treatment groups, in treatment-naïve chronic hepatitis C genotype 2/3 patients.
Inclusion criteria
- Chronic Hepatitis C Genotype 2 and 3 patients